Nanjing Zenshine Pharmaceuticals Co., Ltd.
A commercial-stage biopharmaceutical company focused on innovative therapies for viral infectious diseases, oncology, and inflammation.
Last updated September 1, 2026
AI crawler reads
No AI crawler has read this profile since Oct 28, 2026.
Overview
Nanjing Zenshine Pharmaceuticals Co., Ltd. is a commercial-stage biopharmaceutical company dedicated to discovering, developing, and commercializing innovative therapies to address unmet clinical needs in viral infectious diseases, oncology, and inflammation. The company's history traces back to 2018, founded by a senior leadership team with deep expertise in biopharmaceutical R&D. Its core product, Maxiloxavir tablets, a new-generation oral anti-influenza drug, has been approved for marketing by the National Medical Products Administration.
History
The company's history traces back to 2018, founded by a senior leadership team with deep expertise in biopharmaceutical R&D. It successfully developed its core product, Maxiloxavir tablets, a new-generation oral anti-influenza drug, which has been approved for marketing by the National Medical Products Administration.
Sources3 sources
Cite this profile: Cite the canonical profile. /brand-wiki/nanjing-zenshine-pharmaceuticals-co-ltd-china · Editorial policy · How profiles are compiled